[REFERENCE TRANSLATION]
Please note that this translation is to be used solely as reference and the financial statements in this material are unaudited. In case of any discrepancy between this translation and the Japanese original, the latter shall prevail.
This translation is subject to change without notice. Linical Co., Ltd. shall accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.
Summary of Consolidated Financial Results | |
for the Three Months Ended June 30, 2024 | |
(Japanese GAAP) | |
August 14, 2024 | |
Company name | ：Linical Co., Ltd. |
Stock Listing | ：Tokyo Stock Exchange |
Code No. | ：2183 |
URL | ：https://www.linical.com/ja/ |
Representative | ：Kazuhiro Hatano, Representative Director and President & CEO |
Contact | ：Akihiro Takahashi, Global Chief Financial Officer |
Scheduled date of start of dividend payment | : － | |||||||||||||||||||
Preparation of supplementary materials for the financial | : Yes | |||||||||||||||||||
statements | ||||||||||||||||||||
Holding of presentation financial results | : No | |||||||||||||||||||
（All amounts are rounded down to the nearest million yen） | ||||||||||||||||||||
1．Consolidated Financial Results for the Three Months Ended June 30, 2024（April 1, 2024 to June 30, 2024） | ||||||||||||||||||||
(1)Consolidated Financial Results (cumulative) | （% figures show year-on-year change） | |||||||||||||||||||
Net sales | Operating income | Ordinary income | Profit attributable to | |||||||||||||||||
owners of parent | ||||||||||||||||||||
Three Months Ended | (¥ million) change(％) | (¥ million) | change(％) | (¥ million) | change(％) | (¥ million) | change(％) | |||||||||||||
June 30, 2024 | 2,926 | △5.0 | △66 | － | △47 | － | △82 | － | ||||||||||||
June 30, 2023 | 3,082 | 7.4 | 112 | － | 168 | 87.5 | 3 | △95.4 | ||||||||||||
（Note） Comprehensive income | Three Months Ended June 30, 2024: | ¥287 million (△31.4%) | ||||||||||||||||||
Three Months Ended June 30, 2023: | ¥419 million (△7.2%) | |||||||||||||||||||
Net income per share | Diluted net income | |||||||||||||||||||
per share | ||||||||||||||||||||
Three Months Ended | (¥) | (¥) | ||||||||||||||||||
June 30, 2024 | △3.64 | － | ||||||||||||||||||
June 30, 2023 | 0.16 | － | ||||||||||||||||||
(2)Consolidated Financial Position | ||||||||||||||||||||
Total assets | Net assets | Shareholders' | Net asset per | |||||||||||||||||
equity ratio | share | |||||||||||||||||||
(¥ million) | (¥ million) | |||||||||||||||||||
(％) | (¥) | |||||||||||||||||||
As of June 30, 2024 | 18,984 | 8,183 | 43.1 | 362.32 | ||||||||||||||||
As of March 31, 2024 | 18,539 | 8,235 | 44.4 | 364.60 | ||||||||||||||||
（Reference）Shareholder's equity: | As of June | 30, 2024: | ¥8,183 million |
As of March | 31, 2024: | ¥8,235 million |
2．Dividends | |||||||||||||||||||
Annual dividends per share (¥) | |||||||||||||||||||
1st Quarter End | 2nd Quarter End | 3rd Quarter End | Fiscal | Total | |||||||||||||||
Year End | |||||||||||||||||||
Year Ended March 31, 2024 | － | 0.00 | － | 15.00 | 15.00 | ||||||||||||||
Year Ending March 31, 2025 | － | ||||||||||||||||||
Year Ending March 31, | 0.00 | － | 16.00 | 16.00 | |||||||||||||||
2025(Forecast) | |||||||||||||||||||
(Note）Change in the dividend forecast from the most recent announcement: No | |||||||||||||||||||
3．Forecast of Consolidated Financial Result for the Year Ending March 31, 2025 | |||||||||||||||||||
(April 1, 2024 to March 31, 2025) | （% figures show year-on-year change） | ||||||||||||||||||
Net sales | Operating income | Ordinary income | Profit attributable | Net income | |||||||||||||||
to owners of | |||||||||||||||||||
per share | |||||||||||||||||||
parent | |||||||||||||||||||
(¥ million) | ％ | (¥ million) | ％ | (¥ million) | ％ | (¥ million) | ％ | (¥) | |||||||||||
Full year | 12,669 | 2.9 | 1,009 | 39.0 | 1,047 | 32.5 | 697 | 106.1 | 30.86 |
(Note）Change in forecasts of consolidated financial results from the most recent announcement: No
※ Notes | ||||
(1)Significant changes in the scope of consolidation during the period: | ：No | |||
New: | - | (Company Name) | - | |
Exclusion: | - | (Company Name) | - |
(2)Adoption of accounting methods specific to the preparation of quarterly consolidated financial statements
(3)Changes in accounting policies, accounting estimates and restatement of corrections
1)Changes in accounting policies resulting from the revision of the accounting standards and other regulations
2)Changes in accounting policies other than 1) 3)Changes in accounting estimates 4)Restatement of corrections
(4)Number of issued shares (Common share)
(a)Number of issued shares at the end of the period (including treasury shares)
：No
：No
：No
：No
：No
As of | June 30, 2024 |
As of | March 31, 2024 |
(b) Number of treasury shares at the end of the period
As of | June 30, 2024 |
As of | March 31, 2024 |
- Average number of shares during the period Three Months Ended June 30, 2024 Three Months Ended June 30, 2023
：24,740,000 shares
：24,740,000 shares
- 2,153,564 shares
- 2,153,564 shares
：22,586,436 shares
：22,586,436 shares
- Review of either Japanese original or English translation of the attached quarterly consolidated financial statements by certified public accountants or an audit firm: None
- Explanation on appropriate use of forecast and other special items
The forward-looking statements herein are based on information currently available to the Company and certain assumptions determined to be reasonable. Actual results may differ significantly from these forecasts due to various factors.
Consolidated Balance Sheets
(Thousands of yen) | ||
As of March 31, 2024 | As of June 30, 2024 | |
Assets | ||
Current assets | ||
Cash and deposits | 7,465,192 | 7,404,407 |
Accounts receivable - trade and contract | 3,463,780 | 3,269,485 |
assets | ||
Prepaid expenses | 255,432 | 230,012 |
Advances paid | 1,265,542 | 1,597,645 |
Other | 320,723 | 502,103 |
Allowance for doubtful accounts | △21,895 | △23,019 |
Total current assets | 12,748,776 | 12,980,635 |
Non-current assets | ||
Property, plant and equipment | 518,770 | 510,325 |
Intangible assets | ||
Goodwill | 3,547,866 | 3,668,741 |
Other | 117,467 | 116,923 |
Total intangible assets | 3,665,333 | 3,785,665 |
Investments and other assets | ||
Investment securities | 272,198 | 282,638 |
Long-term prepaid expenses | 1,382 | 3,609 |
Guarantee deposits | 384,805 | 388,436 |
Deferred tax assets | 948,648 | 1,033,020 |
Total investments and other assets | 1,607,034 | 1,707,704 |
Total non-current assets | 5,791,138 | 6,003,695 |
Total assets | 18,539,915 | 18,984,331 |
Consolidated Balance Sheets
(Thousands of yen) | ||
As of March 31, 2024 | As of June 30, 2024 | |
Liabilities | ||
Current liabilities | ||
Short-term borrowings | 600,000 | 600,000 |
Current portion of long-term borrowings | 493,640 | 458,648 |
Accounts payable - other | 847,585 | 772,986 |
Accrued expenses | 349,336 | 363,197 |
Income taxes payable | 264,241 | 370,448 |
Accrued consumption taxes | 22,481 | 8,807 |
Advances received | 2,521,964 | 2,921,624 |
Deposits received | 2,271,085 | 2,624,497 |
Provision for bonuses | 199,310 | 97,010 |
Other | 199,240 | 130,843 |
Total current liabilities | 7,768,885 | 8,348,065 |
Non-current liabilities | ||
Long-term borrowings | 1,499,950 | 1,399,948 |
Lease liabilities | 304,677 | 294,940 |
Retirement benefit liability | 704,710 | 730,498 |
Other | 26,671 | 27,362 |
Total non-current liabilities | 2,536,008 | 2,452,749 |
Total liabilities | 10,304,894 | 10,800,814 |
Net assets | ||
Shareholders' equity | ||
Share capital | 214,043 | 214,043 |
Retained earnings | 7,315,200 | 6,894,108 |
Treasury shares | △657,461 | △657,461 |
Total shareholders' equity | 6,871,781 | 6,450,689 |
Accumulated other comprehensive income | ||
Valuation difference on available-for- | 25,631 | 33,264 |
sale securities | ||
Foreign currency translation adjustment | 1,287,406 | 1,652,665 |
Remeasurements of defined benefit plans | 50,201 | 46,897 |
Total accumulated other comprehensive | 1,363,239 | 1,732,827 |
income | ||
Total net assets | 8,235,021 | 8,183,516 |
Total liabilities and net assets | 18,539,915 | 18,984,331 |
Consolidated statements of income (cumulative)
(Thousands of yen) | ||
Three months ended | Three months ended | |
June 30, 2023 | June 30, 2024 | |
Net sales | 3,082,097 | 2,926,473 |
Cost of sales | 2,134,705 | 2,202,142 |
Gross profit | 947,392 | 724,331 |
Selling, general and administrative expenses | 835,339 | 790,941 |
Operating profit (loss) | 112,052 | △66,610 |
Non-operating income | ||
Interest income | 3,991 | 14,842 |
Foreign exchange gains | 58,688 | 8,581 |
Total non-operating income | 62,680 | 23,423 |
Non-operating expenses | ||
Interest expenses | 4,536 | 4,253 |
Loss on valuation of investment securities | 1,759 | 504 |
Total non-operating expenses | 6,296 | 4,758 |
Ordinary profit (loss) | 168,436 | △47,945 |
Extraordinary losses | ||
Business restructuring expenses | 104,293 | － |
Total extraordinary losses | 104,293 | － |
Profit (loss) before income taxes | 64,142 | △47,945 |
Income taxes - current | 64,897 | 74,796 |
Income taxes - deferred | △4,287 | △40,446 |
Total income taxes | 60,609 | 34,350 |
Profit (loss) | 3,532 | △82,295 |
Profit (loss) attributable to owners of parent | 3,532 | △82,295 |
Consolidated statements of comprehensive income (cumulative)
(Thousands of yen) | ||
Three months ended | Three months ended | |
June 30, 2023 | June 30, 2024 | |
Profit (loss) | 3,532 | △82,295 |
Other comprehensive income | ||
Valuation difference on available-for-sale | △3,324 | 7,632 |
securities | ||
Foreign currency translation adjustment | 421,036 | 365,258 |
Remeasurements of defined benefit plans, net | △2,202 | △3,303 |
of tax | ||
Total other comprehensive income | 415,509 | 369,587 |
Comprehensive income | 419,042 | 287,292 |
Comprehensive income attributable to | ||
Comprehensive income attributable to owners | 419,042 | 287,292 |
of parent | ||